Catalysts for $ARQT
5 tracked
Oct 27, 2026
earnings
Arcutis Biotherapeutics, Inc. earnings
Arcutis Biotherapeutics, Inc.
→
Oct 4, 2025
approval
ZORYVE (ROFLUMILAST) — FDA approval
Arcutis Biotherapeutics, Inc.
→
Jul 9, 2024
approval
ZORYVE (ROFLUMILAST) — FDA approval
Arcutis Biotherapeutics, Inc.
→
Oct 5, 2023
approval
ZORYVE (ROFLUMILAST) — FDA approval
Arcutis Biotherapeutics, Inc.
→
Jul 29, 2022
approval
ZORYVE (ROFLUMILAST) — FDA approval
Arcutis Biotherapeutics, Inc.
→